Loading Otnox...
Otnox
USUnited States·Buyer: NATIONAL INSTITUTES OF HEALTH NIDA

Role of Glucagon-like Peptide-1 (GLP-1) receptor agonists versus DPP-4 inhibitors for alcohol and substance use disorders in improving HIV-related outcomes and providing health benefits in people living with HIV

Closed·22 Jul 2026

Published

22.07.2026

Open for bids

22.07.2026

Deadline

30.07.2026

© 2026 SIA «Vietne». All rights reserved.